Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;37(2):287-94.
doi: 10.1097/PAS.0b013e31826885fb.

Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis

Affiliations

Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis

Maristela L Onozato et al. Am J Surg Pathol. 2013 Feb.

Abstract

Tumor islands-large collections of tumor cells isolated within alveolar spaces-can be seen in lung adenocarcinomas. Recently we observed by 3-dimensional reconstruction that these structures were connected with each other and with the main tumor in different tissue planes, raising the possibility of tumor islands being a means of extension. However, the clinical and prognostic significance of tumor islands remains unknown. In this study, we compared clinicopathologic and molecular characteristics and prognosis of stages I to II lung adenocarcinomas with tumor islands (n=58) and those without (n=203). Lung adenocarcinomas with tumor islands were more likely to occur in smokers, exhibit higher nuclear grade and a solid or micropapillary pattern of growth, and harbor KRAS mutations. In contrast, lung adenocarcinomas without tumor islands were more likely to present as minimally invasive adenocarcinoma, show a lepidic pattern of growth, and harbor EGFR mutations. Although there was no difference in stage, the prognosis of lung adenocarcinomas with tumor islands was significantly worse than those without. The 5-year recurrence-free survival for patients with tumor islands and those without was 44.6% and 74.4%, respectively (log rank P=0.010). The survival difference remained significant (P <0.020) by multivariate analysis, and the presence of tumor islands was associated with almost 2-fold increase in the risk of recurrence. Even in the stage IA cohort, more than half of the patients with tumor islands experienced recurrence within 5 years. Thus, aggressive surveillance and/or further intervention may be indicated for patients whose tumors exhibit tumor islands.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

For all the authors no conflicts of interest were declared.

Figures

Figure 1
Figure 1
(A) Top view of 3D-reconstructed image of lung adenocarcinoma showing tumor islands. (B–J) Fifty whole-slide images of a serial-sectioned paraffin embedded specimen were combined and a 3D image was obtained to study the structure of the tumor islands and its relation with surrounding structures. (B–D) Different planes of view are shown depicting the islands running deep into the tissue (arrows). (B, E–J) Neighboring islands tend to connect (arrow heads and asterisks) and at certain points merge with the main solid tumor (white arrow heads).
Figure 2
Figure 2
(A) An example of lung adenocarcinoma with tumor islands. The islands are isolated within airspaces (arrows) and are several alveoli away from the main tumor (arrow heads). (B) A high-power view shows clusters of atypical cells with necrosis (arrows). The arrowheads indicate a collection of benign alveolar macrophages in the adjacent air space with significant difference in cytology between the two groups. (C) Another example of lung adenocarcinoma with tumor islands. The islands are present in the alveoli adjacent to the blue-inked wedge resection margin (arrowheads). (D) Keratin stain highlights the tumor islands confirming an epithelial origin. Conversely, a cluster of alveolar macrophages (arrows) are negative for keratin. (Immuno stain for pan-keratin on a deeper section of C).
Figure 3
Figure 3
(A) For all stages, median recurrence-free survival was 55 months after resection among subjects with tumor islands (n=56) and undefined among those without tumor islands (n=174). The five-year recurrence-free survival for subjects with tumor islands and those without was 44.6% and 74.4%, respectively (log-rank p = 0.010). (B) For cases with frank invasive carcinomas, median recurrence-free survival was 58 months after resection among subjects with tumor islands (n=56) and undefined among those without tumor islands (n=174). The five-year recurrence-free survival for patients with tumor islands and those without was 46.5% and 70.7%, respectively (log-rank p = 0.046). (C) For Stage IA cases, median survival was 55 months after resection among patients with Stage IA lung adenocarcinomas exhibiting tumor islands (n=35) and undefined among those without tumor islands (n=116). Five-year recurrence-free survival for patients with tumor islands and those without was 44.1% and 77.8%, respectively (log-rank p = 0.011). (D) For subjects who underwent isolated wedge resections, the median survival was undefined among those with tumor islands (n=16) as well as among those without tumor islands (n=66). There was no difference in the five-year recurrence-free survival between subjects with tumor islands and those without (59.3% vs. 68.8%, log-rank p = 0.317); however, the presence of tumor islands was associated with early recurrence (< 2 years) after resection.

Similar articles

Cited by

References

    1. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: A decade of progress. Chest. 2002;122:1037–1057. - PubMed
    1. Mino-Kenudson M, Mark EJ. Reflex testing for epidermal growth factor receptor mutation and anaplastic lymphoma kinase fluorescence in situ hybridization in non-small cell lung cancer. Arch Pathol Lab Med. 2011;135:655–664. - PubMed
    1. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–285. - PMC - PubMed
    1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) National Cancer Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2009_pops09/
    1. Rena O, Papalia E, Ruffini E, et al. Stage i pure bronchioloalveolar carcinoma: Recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg. 2003;23:409–414. - PubMed

Publication types

MeSH terms